Dolores Isla Casado on Muck Rack

Dolores Isla Casado

As seen in: Dialnet - Universidad de La Rioja
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Dolores Isla

Contact Dolores Isla, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Recommendations for diagnosis and management of non-small-cell lung carcinoma patients with ex20ins EGFR mutations: insights from a Delphi consensus

|
By Dolores Isla Casado, Esther Conde, Atocha Romero, Margarita Garrido
| Dialnet - Universidad de La Rioja
Ayuda Buscar en la ayuda Buscar en la ayuda Recommendations for diagnosis and management of non-small-cell lung carcinoma patients with ex20ins EGFR mutations: insights from a Delphi consensus Dolores Isla [1] ; Esther Conde [2] ; Atocha Romero [3] ; Margarita Garrido [4] ; Juan Francisco Marín [5] ; Bartomeu Massuti [6] ; Ihab Abdulkader-Nallib [7] ; María-Josep Carreras [8] ; Marta Marina [9] ; José M.
Open in Who Shared Issue with article?

Factores de riesgo de deterioro cognitivo asociado a cáncer en pacientes con carcinoma de mama y colon que reciben tratamiento con quimioterapia

|
By Ana Perez, Ana Pérez Verified, Julio Sanchez, Dolores Isla Casado, Sebastián Menao Guillen
| Dialnet - Universidad de La Rioja
Ana Callejo [1] ; Julio Arbej [2] ; Sebastian Menao [2] ; Dolores Isla [2] ; Raquel Andrés [2] [1] Hospital Universitario Vall d’Hebron. Barcelona. España [2] Hospital Clínico Universitario Lozano Blesa. Zaragoza. España. Localización: Anales del sistema sanitario de Navarra, ISSN 1137-6627, Vol. 46, Nº. 2, 2023, págs.
Open in Who Shared Issue with article?

New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

|
By Dolores Isla Casado, Maria Lozano Verified, Luis Paz-Ares Rodríguez, Luis Rodriguez, Clara Salas Antón
| Dialnet - Universidad de La Rioja
Resumen Non-small cell lung cancer (NSCLC) presents the greatest number of identified therapeutic targets, some of which have therapeutic utility. Currently, detecting EGFR, BRAF, KRAS and MET mutations, ALK, ROS1, NTRK and RET translocations, and PD-L1 expression in these patients is considered essential.
Open in Who Shared Issue with article?
See all 5 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified